#CysticFibrosis

Techseriesinsight > Blog > #CysticFibrosis

July 16, 2025
Business Wire
Biotechnology, Healthcare, News

CF Foundation Pledges $24M for Gene Therapy

Today, the Cystic Fibrosis Foundation announced an additional investment of up to $24 million in Prime Medicine to continue the development of a gene editing therapy for people with...

July 1, 2025
Business Wire
Biotechnology, Healthcare, News

Vertex’s ALYFTREK® Approved by European Commission

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for ALYFTREK® (deutivacaftor/tezacaftor/vanzacaftor)for the treatment of people with cystic fibrosis (CF) ages 6 years and older who have...